Literature DB >> 26468695

Disappointing Success of Electrical Cardioversion for New-Onset Atrial Fibrillation in Cardiosurgical ICU Patients.

Mattia Arrigo1, Natalie Jaeger, Burkhardt Seifert, Donat R Spahn, Dominique Bettex, Alain Rudiger.   

Abstract

OBJECTIVES: To assess the success of electrical cardioversion for the treatment of new-onset atrial fibrillation in critically ill patients and to evaluate the stability of sinus rhythm in responders during the subsequent 24 hours.
DESIGN: Retrospective study.
SETTING: Twelve-bed cardiosurgical ICU at a university hospital. PATIENTS: Seventy-two consecutive patients with postoperative new-onset atrial fibrillation (<7 d of duration) treated by electrical cardioversion.
INTERVENTIONS: Electrical cardioversion using synchronized biphasic shocks.
MEASUREMENTS AND MAIN RESULTS: During 144 electrical cardioversions, 209 shocks were delivered to 72 patients. Maximal energy (200 J) was used in 85% of shocks. Electrical cardioversion immediately restored sinus rhythm in 102 sessions (71%). Pretreatment with amiodarone did not increase the success rates. During the follow-up, the percentages of sinus rhythm decreased from 43% after 1 hour to 23% after 24 hours. However, at ICU discharge, 54 patients (75%) were in sinus rhythm. Of the 54 patients in sinus rhythm, only 18 (33%) converted to sinus rhythm after repeated cardioversions, whereas the remaining 36 (66%) did so spontaneously or with amiodarone.
CONCLUSIONS: Biphasic electrical cardioversion in cardiosurgical ICU patients was immediately successful in restoring sinus rhythm in 71% of sessions. However, early relapse of atrial fibrillation was common in the 24-hour follow-up. At ICU discharge, the majority of patients were in sinus rhythm, but the efficacy of repetitive electrical cardioversion in restoring sinus rhythm was disappointing.

Entities:  

Mesh:

Year:  2015        PMID: 26468695     DOI: 10.1097/CCM.0000000000001257

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

Review 1.  Atrial Fibrillation in the ICU.

Authors:  Nicholas A Bosch; Jonathan Cimini; Allan J Walkey
Journal:  Chest       Date:  2018-04-06       Impact factor: 9.410

2.  Acute rate control in atrial fibrillation: an urgent need for the clinician.

Authors:  Gheorghe-Andrei Dan; Anca R Dan; Andreea Ivanescu; Adrian C Buzea
Journal:  Eur Heart J Suppl       Date:  2022-06-13       Impact factor: 1.624

3.  Current practice in the management of new-onset atrial fibrillation in critically ill patients: a UK-wide survey.

Authors:  Chung Shen Chean; Daniel McAuley; Anthony Gordon; Ingeborg Dorothea Welters
Journal:  PeerJ       Date:  2017-09-08       Impact factor: 2.984

4.  Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: protocol of a prospective randomised double-blind study.

Authors:  Martin Balik; Petr Waldauf; Michal Maly; Vojtech Matousek; Tomas Brozek; Jan Rulisek; Michal Porizka; Robert Sachl; Michal Otahal; Petr Brestovansky; Eva Svobodova; Marek Flaksa; Zdenek Stach; Jaroslav Pazout; Frantisek Duska; Ondrej Smid; Martin Stritesky
Journal:  BMJ Open       Date:  2019-09-03       Impact factor: 2.692

Review 5.  Right Ventricular Failure: Pathophysiology, Diagnosis and Treatment.

Authors:  Mattia Arrigo; Lars Christian Huber; Stephan Winnik; Fran Mikulicic; Federica Guidetti; Michelle Frank; Andreas J Flammer; Frank Ruschitzka
Journal:  Card Fail Rev       Date:  2019-11-04

6.  Primary success of electrical cardioversion for new-onset atrial fibrillation and its association with clinical course in non-cardiac critically ill patients: sub-analysis of a multicenter observational study.

Authors:  Nozomu Shima; Kyohei Miyamoto; Seiya Kato; Takuo Yoshida; Shigehiko Uchino
Journal:  J Intensive Care       Date:  2021-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.